Ara
Toplam kayıt 4, listelenen: 1-4
COVID-19 Infection in Peritoneal Dialysis Patients: A Comparative Outcome Study with Patients on Hemodialysis and Patients without Kidney Disease
(AVES, 2022)
Objectives: There is limited data about coronavirus disease-19 (COVID-19) characteristics and results in peritoneal dialysis (PD) patients. This study aimed to investigate the characteristics and outcomes among PD patients ...
The effects of tacrolimus and mycophenolate mofetil on regression of encapsulating peritoneal sclerosis in a rat model
(ASOC REGIONAL DIALISIS TRASPLANTES RENALES, 2021)
Objective: Encapsulating peritoneal sclerosis (EPS) is a rare, but potentially fatal complication of peritoneal dialysis. Currently, treatment of peritoneal fibrosis is not fully possible yet. In this study, we aimed to ...
Could Peritoneal Dialysis be an Option for the Treatment of Congestive Heart Failure?
(Türk Nefroloji Derneği, 2022)
bjective: Heart failure is a progressive and fatal disease even with appropriate treatment. Hypervolemia is a major cause of mortality and hospital admissions in these patients. Peritoneal dialysis has been successfully ...
Serum soluble Fas-ligand levels and flow-mediated vasodilation in patients undergoing peritoneal dialysis
(State Institution Institute of Nephrology of the National Academy of Medical Science of Ukraine, 2022)
Flow-mediated vasodilation (FMD) has been demonstrated to be a useful, non-invasive tool for the detection ofendothelialdysfunction in atherosclerotic cardiovascular disease, the leading cause of mortality in end-stage ...